Koppers Holdings announced plans to discontinue distillation and chemical manufacturing at its Stickney, Illinois facility by December 31, 2026, due to high costs, aging infrastructure, and supply issues. The company will move production to its more modern facility in Nyborg, Denmark, aiming to improve margins and cash flow. This move will impact about 85 employees and is expected to generate annual savings of $15-$20 million in adjusted EBITDA and improve free cash flow by $15-$25 million. Koppers expects pre-tax charges of $227-$262 million through 2029 related to the closure but anticipates long-term profitability benefits.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
